Chiara Molinelli

665 total citations
30 papers, 261 citations indexed

About

Chiara Molinelli is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chiara Molinelli has authored 30 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 15 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chiara Molinelli's work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Treatment and Pharmacology (13 papers). Chiara Molinelli is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Treatment and Pharmacology (13 papers). Chiara Molinelli collaborates with scholars based in Italy, Belgium and Spain. Chiara Molinelli's co-authors include Matteo Lambertini, Eva Blondeaux, Lucia Del Mastro, Evandro de Azambuja, Francesca Poggio, Guilherme Nader Marta, Benedetta Conte, Sergio Bertoglio, Flavia Jacobs and Emanuela Varaldo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Chiara Molinelli

26 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Molinelli Italy 9 158 80 79 47 39 30 261
Solange Moraes Sanches Brazil 11 183 1.2× 84 1.1× 125 1.6× 56 1.2× 7 0.2× 34 375
J Jueckstock Germany 9 163 1.0× 61 0.8× 96 1.2× 19 0.4× 5 0.1× 31 374
Eric Pujade Lauraine France 9 150 0.9× 54 0.7× 21 0.3× 16 0.3× 9 0.2× 20 333
C. Gog Germany 10 183 1.2× 69 0.9× 33 0.4× 16 0.3× 2 0.1× 28 341
Stephen Greco United States 10 60 0.4× 227 2.8× 75 0.9× 128 2.7× 3 0.1× 32 359
David D. W. Twa Canada 11 283 1.8× 42 0.5× 26 0.3× 15 0.3× 6 0.2× 14 487
Edibaldo Silva United States 8 50 0.3× 46 0.6× 94 1.2× 20 0.4× 2 0.1× 16 254
Michael Taylor United States 8 60 0.4× 69 0.9× 13 0.2× 10 0.2× 10 0.3× 11 271
Rubén Olivares Chile 13 103 0.7× 147 1.8× 49 0.6× 25 0.5× 2 0.1× 33 383
Hiltje de Graaf Netherlands 9 152 1.0× 56 0.7× 67 0.8× 16 0.3× 19 229

Countries citing papers authored by Chiara Molinelli

Since Specialization
Citations

This map shows the geographic impact of Chiara Molinelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Molinelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Molinelli more than expected).

Fields of papers citing papers by Chiara Molinelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Molinelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Molinelli. The network helps show where Chiara Molinelli may publish in the future.

Co-authorship network of co-authors of Chiara Molinelli

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Molinelli. A scholar is included among the top collaborators of Chiara Molinelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Molinelli. Chiara Molinelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Poggio, Francesca, et al.. (2024). Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification. Current Opinion in Oncology. 36(6). 495–502. 3 indexed citations
5.
Molinelli, Chiara, Flavia Jacobs, Guilherme Nader Marta, et al.. (2024). Ovarian Suppression: Early Menopause and Late Effects. Current Treatment Options in Oncology. 25(4). 523–542. 5 indexed citations
6.
Battistuzzi, Linda, Eva Blondeaux, Francesca Poggio, et al.. (2024). Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer. BMC Palliative Care. 23(1). 129–129.
7.
Sirico, Marianna, Flavia Jacobs, Chiara Molinelli, et al.. (2024). Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond. Critical Reviews in Oncology/Hematology. 200. 104404–104404. 4 indexed citations
8.
Debien, Véronique, Virginie Adam, Elisa Agostinetto, et al.. (2023). DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer. Future Oncology. 19(24). 1655–1667. 3 indexed citations
9.
Marta, Guilherme Nader, Chiara Molinelli, Véronique Debien, et al.. (2023). Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment. Therapeutic Advances in Medical Oncology. 15. 2628415–2628415. 17 indexed citations
10.
Martins-Branco, Diogo, Guilherme Nader Marta, Chiara Molinelli, et al.. (2023). Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis. European Journal of Cancer. 194. 113358–113358. 7 indexed citations
11.
Molinelli, Chiara, Flavia Jacobs, Elisa Agostinetto, et al.. (2023). Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis.. Journal of Clinical Oncology. 41(16_suppl). 1104–1104. 2 indexed citations
12.
Jacobs, Flavia, Chiara Molinelli, Diogo Martins-Branco, et al.. (2023). Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis. European Journal of Cancer. 197. 113478–113478. 1 indexed citations
13.
14.
Molinelli, Chiara, Flavia Jacobs, Elisa Agostinetto, et al.. (2023). Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis. ESMO Open. 8(4). 101592–101592. 43 indexed citations
15.
Debien, Véronique, Guilherme Nader Marta, Elisa Agostinetto, et al.. (2023). Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab. Critical Reviews in Oncology/Hematology. 190. 104089–104089. 2 indexed citations
16.
Molinelli, Chiara, Flavia Jacobs, Caterina Marchiò, et al.. (2022). HER2-Low Breast Cancer: Where Are We?. Breast Care. 17(6). 533–545. 13 indexed citations
17.
Conte, Benedetta, Filippo Montemurro, Alessia Levaggi, et al.. (2022). Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial. Tumori Journal. 109(1). 71–78. 3 indexed citations
18.
Poggio, Francesca, Marco Tagliamento, Davide Soldato, et al.. (2020). Update on the Management of Breast Cancer during Pregnancy. Cancers. 12(12). 3616–3616. 38 indexed citations
19.
Molinelli, Chiara, Lucia Del Mastro, S. Giraudi, et al.. (2020). 226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study. Annals of Oncology. 31. S331–S331. 1 indexed citations
20.
Nichetti, Federico, Antonio Marra, Carlo Alberto Giorgi, et al.. (2020). 337P Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study. Annals of Oncology. 31. S382–S382. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Solange Moraes Sanches Breakdown of academic impact, for papers by J Jueckstock Breakdown of academic impact, for papers by Eric Pujade Lauraine Breakdown of academic impact, for papers by C. Gog Breakdown of academic impact, for papers by Stephen Greco Breakdown of academic impact, for papers by David D. W. Twa Breakdown of academic impact, for papers by Edibaldo Silva Breakdown of academic impact, for papers by Michael Taylor Breakdown of academic impact, for papers by Rubén Olivares Breakdown of academic impact, for papers by Hiltje de Graaf
Rankless by CCL
2026